The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection.
COVID-19
SARS-CoV-2
antidepressants
clomipramine
inflammation
psychiatric pathology
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
10
2020
accepted:
04
02
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
3
2021
Statut:
epublish
Résumé
At the time of writing (December 2020), coronavirus disease 2019 (COVID-19) has already caused more than one million deaths worldwide, and therefore, it is imperative to find effective treatments. The "cytokine storm" induced by Severe Acute Respiratory Syndrome-Coronavirus type 2 (SARS-CoV-2) is a good target to prevent disease worsening, as indicated by the results obtained with tocilizumab and dexamethasone. SARS-CoV-2 can also invade the brain and cause neuro-inflammation with dramatic neurological manifestations, such as viral encephalitis. This could lead to potentially incapacitating long-term consequences, such as the development of psychiatric disorders, as previously observed with SARS-CoV. Several pathways/mechanisms could explain the link between viral infection and development of psychiatric diseases, especially neuro-inflammation induced by SARS-CoV-2. Therefore, it is important to find molecules with anti-inflammatory properties that penetrate easily into the brain. For instance, some antidepressants have anti-inflammatory action and pass easily through the blood brain barrier. Among them, clomipramine has shown very strong anti-inflammatory properties
Identifiants
pubmed: 33767623
doi: 10.3389/fphar.2021.615695
pii: 615695
pmc: PMC7985338
doi:
Types de publication
Journal Article
Langues
eng
Pagination
615695Informations de copyright
Copyright © 2021 Nobile, Durand, Olié, Guillaume, Molès, Haffen and Courtet.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Comput Biol Med. 2015 Dec 1;67:1-12
pubmed: 26476562
Curr Neuropharmacol. 2016;14(7):732-42
pubmed: 27640518
Acta Neurochir (Wien). 2003 Aug;145(8):683-90
pubmed: 14520549
Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93
pubmed: 24841273
Eur Neuropsychopharmacol. 2006 Oct;16(7):481-90
pubmed: 16388933
Transl Psychiatry. 2020 Oct 6;10(1):339
pubmed: 33024072
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Cancers (Basel). 2020 Nov 30;12(12):
pubmed: 33266177
J Neurol. 2020 Jul;267(7):1880-1882
pubmed: 32361836
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
Neurochem Res. 2019 Jun;44(6):1410-1424
pubmed: 30661228
J Affect Disord. 2019 Jul 1;254:15-25
pubmed: 31082627
Infez Med. 2020 Ahead of print Jun 1;28(2):174-184
pubmed: 32275259
Neuroscience. 2013 Aug 29;246:199-229
pubmed: 23644052
J Psychopharmacol. 2010 Aug;24(8):1261-8
pubmed: 19553387
Transl Psychiatry. 2014 Jul 01;4:e405
pubmed: 24984192
Neuropharmacology. 2017 Jan;112(Pt B):297-306
pubmed: 27245499
J Virol. 2012 Apr;86(8):4234-44
pubmed: 22345460
Mol Med. 2020 Jun 29;26(1):64
pubmed: 32600316
Neuroscientist. 2020 Sep 11;:1073858420956905
pubmed: 32914699
Int J Antimicrob Agents. 2020 Jun;55(6):105969
pubmed: 32278811
Microb Pathog. 2021 Jan;150:104673
pubmed: 33278517
Brain Behav Immun. 2020 Aug;88:17-27
pubmed: 32416290
Neuroscientist. 2020 Nov 2;:1073858420967892
pubmed: 33135582
Eur Neuropsychopharmacol. 2000 Sep;10(5):401-5
pubmed: 10974613
Brain Behav Immun Health. 2020 May;5:100076
pubmed: 32322822
Cell Mol Life Sci. 2018 Oct;75(19):3625-3634
pubmed: 29679094
Neuropsychopharmacology. 2017 Jan;42(1):193-215
pubmed: 27629368
Eur J Pharmacol. 1997 Jan 29;319(2-3):287-90
pubmed: 9042603
J Autoimmun. 1998 Aug;11(4):319-27
pubmed: 9776709
Trends Mol Med. 2018 Nov;24(11):950-962
pubmed: 30314877
Acta Psychiatr Scand. 2015 Sep;132(3):192-203
pubmed: 26256862
Nature. 2020 Sep;585(7825):342-343
pubmed: 32934351
Curr Psychiatry Rep. 2019 Jul 3;21(8):72
pubmed: 31267432
PLoS One. 2020 May 11;15(5):e0233147
pubmed: 32392262
Lancet Digit Health. 2020 Jun;2(6):e286-e287
pubmed: 32363333
J Psychopharmacol. 2010 Aug;24(8):1165-74
pubmed: 19460870
Eur Neuropsychopharmacol. 2001 Jun;11(3):203-8
pubmed: 11418279
Anticancer Res. 2010 Feb;30(2):391-7
pubmed: 20332444
Drugs. 2017 Dec;77(18):1935-1966
pubmed: 29143192
Brain Behav Immun. 2020 Aug;88:39-43
pubmed: 32464158
Virus Res. 2008 Apr;133(1):101-12
pubmed: 17451827
J Affect Disord. 2011 Apr;130(1-2):220-5
pubmed: 21030090
Clin Infect Dis. 2005 Oct 15;41(8):1089-96
pubmed: 16163626
Sci Rep. 2017 Mar 10;7:44277
pubmed: 28281674
Eur Arch Psychiatry Clin Neurosci. 1997;247(4):228-33
pubmed: 9332905
Front Immunol. 2020 Jun 11;11:1359
pubmed: 32595653
Brain Behav Immun. 2020 Jul;87:34-39
pubmed: 32298803
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Aust N Z J Psychiatry. 2020 Oct 1;:4867420961472
pubmed: 32998512
Emerg Microbes Infect. 2014 Dec;3(12):e84
pubmed: 26038505
ACS Chem Neurosci. 2020 Mar 4;11(5):752-762
pubmed: 32011849
J Med Virol. 2020 Oct;92(10):1743-1744
pubmed: 32246784
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Curr Pharm Des. 2016;22(8):949-54
pubmed: 26654774
Soc Psychiatry Psychiatr Epidemiol. 2014 Jun;49(6):841-9
pubmed: 24789456
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
Curr Top Behav Neurosci. 2020;45:47-69
pubmed: 32601996
Psychoneuroendocrinology. 2015 Jan;51:237-52
pubmed: 25462897
Immune Netw. 2017 Apr;17(2):77-88
pubmed: 28458619
Nat Rev Neurol. 2019 Jun;15(6):317-328
pubmed: 30988501
Gen Pharmacol. 1994 May;25(3):409-12
pubmed: 7926582
Neuropharmacology. 2008 Oct;55(5):826-34
pubmed: 18639562
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
Front Hum Neurosci. 2016 Nov 10;10:571
pubmed: 27891086
Immunopharmacology. 1996 Aug;34(1):27-37
pubmed: 8880223
J Neuroimmune Pharmacol. 2020 Sep;15(3):347-348
pubmed: 32601885
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Neuropsychopharmacology. 2011 Nov;36(12):2452-9
pubmed: 21796103
Clin Immunol. 2020 Jun;215:108448
pubmed: 32353634
Psychiatry Res. 2005 Apr 30;134(3):251-8
pubmed: 15892984
Neuropsychopharmacology. 1999 Apr;20(4):370-9
pubmed: 10088138
Schizophr Bull. 2011 Jan;37(1):101-7
pubmed: 19491313
Braz J Psychiatry. 2013 Oct-Dec;35(4):387-92
pubmed: 24402214
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Nat Rev Immunol. 2019 Aug;19(8):477-489
pubmed: 31036962
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
Brain Behav Immun. 2020 Jul;87:49-50
pubmed: 32304883
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):407-412
pubmed: 32335367
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Front Neurol. 2020 Oct 27;11:571996
pubmed: 33193019
Brain Behav Immun. 2020 Jul;87:59-73
pubmed: 32334062
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
N Engl J Med. 2020 Feb 20;382(8):692-694
pubmed: 31978293
J Exp Med. 1991 Nov 1;174(5):1209-20
pubmed: 1940799
Nat Commun. 2017 Dec 19;8(1):1990
pubmed: 29259169
C R Biol. 2020 Jun 05;343(1):33-39
pubmed: 32720486
World J Biol Psychiatry. 2016 Dec;17(8):564-586
pubmed: 26223957
Sci Transl Med. 2015 Jun 3;7(290):290ra89
pubmed: 26041706
Eur Neuropsychopharmacol. 2010 Jun;20(6):379-87
pubmed: 20231081
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Pharmacol Ther. 2017 Nov;179:1-16
pubmed: 28529069
Pharmacol Res. 2003 Aug;48(2):157-65
pubmed: 12798668
J Nutr Health Aging. 2020;24(7):685-691
pubmed: 32744561
J Psychiatr Res. 2020 Oct;129:98-102
pubmed: 32912598
JAMA Psychiatry. 2020 Jul 31;:
pubmed: 32735332
Eur Neuropsychopharmacol. 2015 Oct;25(10):1532-43
pubmed: 26169573
Arch Immunol Ther Exp (Warsz). 2019 Jun;67(3):143-151
pubmed: 31032529
Mol Neurobiol. 2019 May;56(5):3295-3312
pubmed: 30117106
Eur J Pharmacol. 2002 May 24;444(1-2):13-9
pubmed: 12191577
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
Eur J Neurol. 2020 Dec;27(12):2668-2669
pubmed: 32926584
IUBMB Life. 2017 May;69(5):297-304
pubmed: 28374903
J Clin Psychiatry. 2020 Apr 7;81(3):
pubmed: 32271506
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e13-e18
pubmed: 32841329
Rev Neurol. 2020 May 1;70(9):311-322
pubmed: 32329044
Psychol Med. 2012 Oct;42(10):2015-26
pubmed: 22336436
Immunity. 2011 May 27;34(5):680-92
pubmed: 21616437
Am J Psychiatry. 1995 Dec;152(12):1714-20
pubmed: 8526235
Clin Pharmacokinet. 1991 Jun;20(6):447-62
pubmed: 2044329
Brain Behav Immun. 2013 Jul;31:96-104
pubmed: 23313516
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Biol Aujourdhui. 2017;211(1):93-96
pubmed: 28682230
J Psychosom Res. 2017 Mar;94:47-55
pubmed: 28183402
Psychopharmacology (Berl). 2016 May;233(9):1575-89
pubmed: 26268146
J Infect. 2020 Apr;80(4):394-400
pubmed: 32109443
Microbes Infect. 2013 Feb;15(2):88-95
pubmed: 23123977
Brain Behav Immun. 2014 Feb;36:111-7
pubmed: 24513871
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
J Neurochem. 2020 May;153(4):468-484
pubmed: 31821553
Biotechnol Biotechnol Equip. 2014 May 4;28(3):552-558
pubmed: 26740765
J Pharmacol Exp Ther. 2003 Jan;304(1):1-7
pubmed: 12490568
Br J Psychiatry. 2004 Apr;184:359-60
pubmed: 15056583
Clin Liver Dis. 2017 Aug;21(3):517-534
pubmed: 28689590